tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Westenberg, 195 are a BUY (59.09%), 130 are a HOLD (39.39%), 5 are a SELL (1.52%).
Analyst David Westenberg, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 64.49% that have a potential upside of 24.1% achieved within 151 days.
David Westenberg’s has documented 651 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on TXG, 10X Genomics.
Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for OCX (ONCOCYTE CORP) at 11/13/2023. The price target of $3 was fulfilled within 1 day with a profit of $0.24 (8.7%) receiving and performance score of 86.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2022
$19
$-3.2 (-14.41%)
$15
1 months 26 days ago
(04-Aug-2026)
8/15 (53.33%)
$0.45 (2.43%)
97
Hold Since 05-Aug-2025
$30
$10.04 (50.30%)
1 years 1 months 25 days ago
(05-Aug-2025)
1/1 (100%)
$9.22 (44.37%)
108
Buy Since 18-Nov-2022
$25
$2.8 (12.61%)
$45
1 years 4 months 25 days ago
(05-May-2025)
1/2 (50%)
$5.44 (27.81%)
186
Hold Since 07-Dec-2023
$35
$12.8 (57.66%)
$45
2 years 9 months 23 days ago
(07-Dec-2023)
0/4 (0%)
$8.4 (31.58%)
Buy Since 20-Aug-2020
$125
$102.8 (463.06%)
$141
4 years 8 months 5 days ago
(25-Jan-2022)
4/8 (50%)
$61.5 (96.85%)
70
Which stock is David Westenberg most bullish on?
Which stock is David Westenberg most reserved on?
What Year was the first public recommendation made by David Westenberg?
